BridgeMD
New treatment option for Saccular Aneurysm
Official title Comprehensive Aneurysm Management Trial
ClinicalTrials.gov ID: NCT04155606
What this study is testing
- What it's testing
- The uncertainty regarding the management of Unruptured Intracranial Aneurysms (UIAs) has not progressed in the last 30 years. The fundamental ethical basis for this study is that physicians should only offer a risky preventive treatment when it has been shown to be beneficial.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with at least one documented, intracranial subarachnoid aneurysm (cavernous aneurysms are excluded)
You likely can't join if
- Patients with any intracranial hemorrhage, including SAH, within the previous 30 days
- Patients with AVM-associated aneurysms
- Patients unable to give informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Edmonton, Alberta, Canada
- Montreal, Quebec, Canada
- Tours, France
- Bergamo, Italy
- Lecce, Italy
- Milan, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edmonton, Alberta, Canada; Montreal, Quebec, Canada; Tours, France; Bergamo, Italy; Lecce, Italy; Milan, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.